ELV250516P400000
- 5.20
- +0.30+6.12%
Elevance Health Newsroom
Is Elevance (ELV) an Attractively Valued Stock?
Top Executive Sells Millions in Elevance Health Stock!
Argus Research Maintains Elevance Health(ELV.US) With Buy Rating, Raises Target Price to $465
Trump Likes Concept of Millionaire Tax, Would Veto Medicaid Cuts - Report
A Quick Look at Today's Ratings for Elevance Health(ELV.US), With a Forecast Between $478 to $585
'Medicaid to the Rescue,' Says Wall St. Analyst About Elevance Health (ELV) Stock
Elevance Health's Growth Potential Justifies Buy Rating Amid Sector Challenges
Buy Rating for Elevance Health: Stable Medicaid and Medicare Advantage Outlook With Potential Upside
Deutsche Bank Cuts Elevance Health Price Target to $463 From $465, Maintains Buy Rating
RBC Capital Reiterates Outperform on Elevance Health, Maintains $478 Price Target
Jefferies Adjusts Price Target on Elevance Health to $488 From $461, Maintains Buy Rating
Express News | Guggenheim Reiterates Buy on Elevance Health, Maintains $518 Price Target
Why Elevance Health, Inc. (ELV) Is Among the Best Stocks That Will Always Grow
Elevance Health Is Maintained at Overweight by Barclays
Elevance Health Price Target Raised to $522.00/Share From $512.00 by Barclays
Express News | Barclays Maintains Overweight on Elevance Health, Raises Price Target to $522
Elevance Health Analyst Ratings
Positive Outlook for Elevance Health: Buy Rating Supported by Medicaid Rate Updates and Strategic Moves
Elevance Health: Hold Rating Amid Medicare Cost Pressures and Regulatory Risks
Express News | Elevance Health : Jefferies Raises Target Price to $488 From $461